Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Gillham

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Epilepsia|July 1, 1990
Refractory epilepsy: an evaluation of psychological methods in outpatient managementR A Gillham
Psychosomatics|June 1, 1986
Neuropsychological study of motor neuron diseaseA S David, R A Gillham
British Medical Journal (Clinical Research Ed.)|January 15, 1983
Lithium-induced constructional dyspraxiaE P Worrall, R A Gillham
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1993
Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsyR A Gillham, J Blacklaw, P J McKee, et al.
Epilepsy Research|May 1, 1992
Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patientsP J McKee, J Blacklaw, E Butler, et al.
British Journal of Clinical Pharmacology|July 1, 1991
Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patientsP J McKee, J Blacklaw, E Butler, et al.
British Journal of Clinical Pharmacology|September 1, 1993
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patientsP J McKee, J Blacklaw, A Carswell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patientsR A Gillham, N Williams, K Wiedmann, et al.
Epilepsy Research|December 1, 1990
Cognitive function in adult epileptic patients established on anticonvulsant monotherapyR A Gillham, N Williams, K D Wiedmann, et al.
Epilepsia|September 1, 1993
Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?P J McKee, J Blacklaw, E Friel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Epilepsia|July 1, 1990
Refractory epilepsy: an evaluation of psychological methods in outpatient managementR A Gillham
Psychosomatics|June 1, 1986
Neuropsychological study of motor neuron diseaseA S David, R A Gillham
British Medical Journal (Clinical Research Ed.)|January 15, 1983
Lithium-induced constructional dyspraxiaE P Worrall, R A Gillham
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1993
Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsyR A Gillham, J Blacklaw, P J McKee, et al.
Epilepsy Research|May 1, 1992
Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patientsP J McKee, J Blacklaw, E Butler, et al.
British Journal of Clinical Pharmacology|July 1, 1991
Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patientsP J McKee, J Blacklaw, E Butler, et al.
British Journal of Clinical Pharmacology|September 1, 1993
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patientsP J McKee, J Blacklaw, A Carswell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patientsR A Gillham, N Williams, K Wiedmann, et al.
Epilepsy Research|December 1, 1990
Cognitive function in adult epileptic patients established on anticonvulsant monotherapyR A Gillham, N Williams, K D Wiedmann, et al.
Epilepsia|September 1, 1993
Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?P J McKee, J Blacklaw, E Friel, et al.
Pageof 2